日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Trimodality Therapy for Bladder Cancer: A Single Institution Retrospective Analysis of Factors Associated With Outcomes for High-Risk Patients Undergoing Organ-Sparing Therapy

膀胱癌三联疗法：一项单中心回顾性分析高危患者接受器官保留治疗后预后相关因素

期刊:Clinical Genitourinary Cancer
影响因子:2.7
doi:10.1016/j.clgc.2025.102477
Nair, Monica S; Scarborough, Jessica; Reddy, Chandana A; Bommireddy, Anirudh R; Brooks, Erin; Almassi, Nima; Weight, Christopher J; Campbell, Steven; Ornstein, Moshe C; Nizam, Amanda; Gilligan, Timothy; Wee, Christopher; Gupta, Shilpa; Scott, Jacob G; Mastroianni, Anthony; Tendulkar, Rahul; Mian, Omar Y
肿瘤
肿瘤免疫
膀胱癌
发表日期：2026
文献求助 收藏

Risk of retinal vein occlusions in patients taking systemic tyrosine kinase inhibitors

服用全身性酪氨酸激酶抑制剂的患者发生视网膜静脉阻塞的风险

期刊:
影响因子:
doi:10.1038/s41433-026-04240-7
Mohan, Nitesh; Srivastava, Sunil K; Duphare, Chandni; Gilligan, Timothy D; Ali, Mir Yusuf; Ornstein, Moshe C; Sobecks, Ronald; Shepard, Dale; Sharma, Sumit
信号转导
发表日期：2026
文献求助 收藏

Phase 1b/2 study of batiraxcept alone and in combination with cabozantinib with or without nivolumab for advanced clear cell renal cell carcinoma

一项针对晚期透明细胞肾细胞癌的 1b/2 期研究，评估巴替拉西普单药治疗以及联合卡博替尼（加或不加纳武利尤单抗）治疗晚期透明细胞肾细胞癌的疗效。

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyaf138
Beckermann, Kathryn E; Shah, Neil J; Campbell, Matthew T; Haas, Naomi B; Nelson, Ariel; Ornstein, Moshe C; Mao, Shifeng; Keshava-Prasad, Holavanahalli S; Hammers, Hans; Gao, Xin; Gourdin, Theodore; George, Saby; Hoimes, Christopher J; Hussain, Arif; Jonasch, Eric; Rini, Brian I; Voss, Martin H
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2025
文献求助 收藏

Treatment-free survival outcomes from the phase II study of nivolumab and salvage nivolumab/ipilimumab in advanced clear cell renal cell carcinoma (HCRN GU16-260-Cohort A)

nivolumab 和挽救性 nivolumab/ipilimumab 治疗晚期透明细胞肾细胞癌 II 期研究的无治疗生存结果 (HCRN GU16-260-Cohort A)

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2023-008293
Atkins, Michael B; Jegede, Opeyemi A; Haas, Naomi B; Mcdermott, David F; Bilen, Mehmet A; Stein, Mark; Sosman, Jeffrey; Alter, Robert; Plimack, Elizabeth R; Ornstein, Moshe C; Hurwitz, Michael; Peace, David J; Einstein, David; Catalano, Paul J; Hammers, Hans; Regan, Meredith M
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2024
文献求助 收藏

Treatment Preferences Among Patients with Renal Cell Carcinoma: Results from a Discrete Choice Experiment

肾细胞癌患者的治疗偏好：一项离散选择实验的结果

期刊:Patient Preference and Adherence
影响因子:2
doi:10.2147/PPA.S460994
Ornstein, Moshe C; Rosenblatt, Lisa C; Yin, Xin; Del Tejo, Viviana; Guttenplan, Sarah B; Ejzykowicz, Flavia; Beusterien, Kathleen; Will, Oliver; Mackie, deMauri S; Skiles, Grace; DeCongelio, Marc
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2024
文献求助 收藏

Clinical Outcomes for Metastatic Renal Cell Carcinoma (mRCC) Patients Ineligible for Front-line Clinical Trials

不适合参加一线临床试验的转移性肾细胞癌（mRCC）患者的临床结局

期刊:Journal of Kidney Cancer and VHL
影响因子:1.9
doi:10.15586/jkcvhl.v11i3.352
Reynolds, Nathan; Wei, Wei; Maroli, Kimberly; Bonham, Amanda; Nizam, Amanda; Gilligan, Timothy D; Wee, Christopher; Gupta, Shilpa; Ornstein, Moshe C
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2024
文献求助 收藏

Phase II study of nivolumab and salvage nivolumab/ipilimumab in treatment-naïve patients with advanced non-clear cell renal cell carcinoma (HCRN GU16-260-Cohort B)

nivolumab 和挽救性 nivolumab/ipilimumab 治疗初治晚期非透明细胞肾细胞癌患者的 II 期研究 (HCRN GU16-260-Cohort B)

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2022-004780
Atkins, Michael B; Jegede, Opeyemi A; Haas, Naomi B; McDermott, David F; Bilen, Mehmet A; Stein, Mark; Sosman, Jeffrey A; Alter, Robert; Plimack, Elizabeth R; Ornstein, Moshe C; Hurwitz, Michael; Peace, David J; Signoretti, Sabina; Denize, Thomas; Cimadamore, Alessia; Wu, Catherine J; Braun, David; Einstein, David; Catalano, Paul J; Hammers, Hans
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2023
文献求助 收藏

Avelumab Plus Axitinib as First-Line Therapy for Advanced Renal Cell Carcinoma: Long-Term Results from the JAVELIN Renal 100 Phase Ib Trial

阿维鲁单抗联合阿昔替尼作为晚期肾细胞癌一线治疗：JAVELIN Renal 100 Ib期试验的长期结果

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyac243
Larkin, James; Oya, Mototsugu; Martignoni, Marcella; Thistlethwaite, Fiona; Nathan, Paul; Ornstein, Moshe C; Powles, Thomas; Beckermann, Kathryn E; Balar, Arjun V; McDermott, David; Gupta, Sumati; Philips, George K; Gordon, Michael S; Uemura, Hirotsugu; Tomita, Yoshihiko; Wang, Jing; Michelon, Elisabete; di Pietro, Alessandra; Choueiri, Toni K
肿瘤
肾癌
肿瘤免疫
细胞生物学
发表日期：2023
文献求助 收藏

Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor

播客将讨论接受一线阿昔替尼联合免疫检查点抑制剂治疗的转移性肾细胞癌患者的治疗管理

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-023-02513-1
Ornstein, Moshe C; Wood, Laura S
Checkpoint
肿瘤
肿瘤免疫
肾癌
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏

Correction to: Podcast to Discuss Therapy Management for Patients with Metastatic Renal Cell Carcinoma Receiving First-Line Axitinib Plus an Immune Checkpoint Inhibitor

更正：播客将讨论接受一线阿昔替尼联合免疫检查点抑制剂治疗的转移性肾细胞癌患者的治疗管理

期刊:Advances in Therapy
影响因子:4
doi:10.1007/s12325-023-02593-z
Ornstein, Moshe C; Wood, Laura S
Checkpoint
肿瘤
肿瘤免疫
肾癌
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏